DFS
33
3
MAT
58
2
VRSN
49
-3
OXY
65
4
KEY
34
3
CI
46
-12
STZ
53
-4
MCO
64
2
MS
39
2
HCA
42
3
ACN
58
2
TSCO
58
3
CCI
10
-7
BDX
63
7
DO
48
4
THC
60
2
EIX
37
-3
AMT
30
-2
PNC
40
3
PWR
65
2
DFS
33
3
MAT
58
2
VRSN
49
-3
OXY
65
4
KEY
34
3
CI
46
-12
STZ
53
-4
MCO
64
2
MS
39
2
HCA
42
3
ACN
58
2
TSCO
58
3
CCI
10
-7
BDX
63
7
DO
48
4
THC
60
2
EIX
37
-3
AMT
30
-2
PNC
40
3
PWR
65
2
Financhill
Back

Novo Nordisk A/S Quote, Financials, Valuation and Earnings

Forget 99.987% of Stocks (Use This ONE Instead)

See how to make massive profits by abandoning 8,251 of the 8,252 publicly traded stocks!
Buy
76

NONOF
Novo Nordisk A/S

Last Price:
186.17
Seasonality Move:
-0.05%

7 Day Trial

ALL ACCESS PASS

$ 7

See What One Ticker... One Trade... EVERY WEEK...Can Do for YOU

Show me one ticker payouts.

Novo Nordisk A/S Price Quote

$186.17
+0.00 (+0.42%)
(Updated: September 2, 2023 at 6:17 AM ET)

Novo Nordisk A/S Key Stats

Buy
76
Novo Nordisk A/S (NONOF) is a Buy
Day range:
$185.60 - $191.00
52-week range:
$94.75 - $193.85
Dividend yield:
1.11%
P/E ratio:
53.73
P/S ratio:
14.80
P/B ratio:
31.56%
Volume:
16.5K
Avg. volume:
39K
1-year change:
82.34%
Market cap:
$416.6B
Revenue:
$25.1B
EPS:
$4.21

How Much Does Novo Nordisk A/S Make?

Is Novo Nordisk A/S Growing As A Company?

  • What Is Novo Nordisk A/S's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.5%

Novo Nordisk A/S Stock Price Performance

What Is Novo Nordisk A/S 52-Week High & Low?

Novo Nordisk A/S Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk A/S?

  • How Much Debt Does Novo Nordisk A/S Have?
    Total long term debt quarterly is $3.8B
  • How Much Cash Does Novo Nordisk A/S Have?
    Cash and short term investments quarterly total is $5.3B
  • What Is Novo Nordisk A/S’s Book Value Per Share?
    Book value per share is 5.89

Is Novo Nordisk A/S Cash Flow Positive?

  • What Is NONOF Cash Flow From Operations?
    Cash flow from operations (TTM) is $12.9B
  • What Is Novo Nordisk A/S’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$8B
  • What Is Novo Nordisk A/S’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5B

Novo Nordisk A/S Return On Invested Capital

  • Is Management Doing A Good Job?
    NONOF return on invested capital is 63.4%
  • What Is Novo Nordisk A/S Return On Assets?
    ROA measures how assets are converting to revenues and is 27.17%
  • What Is NONOF Return On Equity?
    ROE is a measure of profitability and is 82.75%

Novo Nordisk A/S Earnings Date & Stock Price

Novo Nordisk A/S Competitors

Novo Nordisk A/S Dividend Yield

Novo Nordisk A/S Analyst Estimates

YoY Growth Past Surprise
EPS: 50.35% 0%
Revenue: 34.34% -2.56%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 178.32
Downside from Last Price: -4.22%

Major Shareholders

  • How many NONOF shares are owned by institutional investors?
    786.4M NONOF shares are owned by institutional investors
  • How many NONOF shares are owned by insiders?
    0 NONOF shares are owned by insiders